Malfunction of vascular control in lifestyle-related diseases: Formation of systemic hemoglobin-nitric oxide complex (HbNO) from dietary nitrite

Journal of Pharmacological Sciences

Volumn 96, Issue 4, 2004, Pages 395-400

  Tsuchiya, Koichiro ^a   Takiguchi, Yoshiharu ^a   Okamoto, Masumi ^a   Izawa, Yuki ^a   Kanematsu, Yasuhisa ^a   Yoshizumi, Masanori ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Electron paramagnetic resonance; Hemoglobin NO adduct; Nitric oxide (NO); Nitrite

Indexed keywords

ARGININE; HEMOGLOBIN; METHEMOGLOBIN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NITROGEN 15; NITROSYLHEMOGLOBIN; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CELL ORGANELLE; DIETARY INTAKE; ELECTRON SPIN RESONANCE; FRUIT; HYPERTENSION; HYPOPHARYNX; KIDNEY ISCHEMIA; LIFESTYLE; NONHUMAN; PH; REPERFUSION INJURY; SHORT SURVEY; STOMACH; VEGETABLE;

EID: 12444292786     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FMJ04006X3     Document Type: Short Survey

References (56)

1. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:3375-3378.
2. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818-2825.
3. Snyder SH, Jaffrey SR, Zakhary R. Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res Brain Res Rev. 1998;26:167-175.
4. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR, et al. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 1998;427;225-228.
5. Feelisch M, Stamler JS. Donors of nitrogen oxides. In: Feelisch M, Stamler JS, editors. Methods in nitric oxide research. Chichester: John Weily & Sons, 1996. p. 71-115.
6. Takahama U, Oniki T, Murata H. The presence of 4-hydroxyphenylacetic acid in human saliva and the possibility of its nitration by salivary nitrite in the stomach. FEBS Lett. 2002; 518:116-118.
7. Lundberg JO, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut. 1994;35:1543-1546.
8. McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, Benjamin N. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut. 1997;40:211-214.
9. Duncan C, Dougall H, Johnston P, Green S, Brogan R, Leifert C, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med. 1995;1:546-551.
10. Lundberg JO, Carlsson S, Engstrand L, Morcos E, Wiklund NP, Weitzberg E. Urinary nitrite: more than a marker of infection. Urology. 1997;50:189-191.
11. Donaldson AN. The relation of protein foods to hypertension. Calif West Med. 1926;24:328-331.
12. Sacks FM, Rosner B, Kass EH. Blood pressure in vegetarians. Am J Epidemiol. 1974;100:390-398.
13. Melby CL, Goldflies DG, Toohey ML. Blood pressure differences in older black and white long-term vegetarians and nonvegetarians. J Am Coll Nutr. 1993;12:262-269.
14. Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WM, McCullough M, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995;5:108-118.
15. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124.
16. Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001; 38:155-158.
17. White JW Jr. Relative significance of dietary sources of nitrate and nitrite. J Agric Food Chem. 1975;23:886-891.
18. Himeno M. Analysis of NOx kinetics in human subjects. J Kanazawa Med Univ. 2001;26:170-180.
19. Mowat C, McColl KE. Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy. Best Pract Res Clin Gastroenterol. 2001;15:523-537.
20. Bartholomew B, Hill MJ. The pharmacology of dietary nitrate and the origin of urinary nitrate. Food Chem Toxicol. 1984;22:789-795.
21. Burgen ASV, Emmelin NG. Physiology of the salivary glands. London: Edward Arnold; 1961.
22. Ellen G, Schuller PL. Nitrate, origin of continuous anxiety. In: Preusmann R, editor. Das Nitrosamin-Problem. Weinheim: Verlag Chemie GmbH; 1983. p. 97-134.
23. Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol. 1976;14:545-548.
24. Beier S, Classen HG, Loeffler K, Schumacher E, Thoni H. Antihypertensive effect of oral nitrite uptake in the spontaneously hypertensive rat. Arzneimittelforschung. 1995;45:258-261.
25. Haas M, Classen HG, Thoni H, Classen UG, Drescher B. Persistent antihypertensive effect of oral nitrite supplied up to one year via the drinking water in spontaneously hypertensive rats. Arzneimittelforschung. 1999;49:318-323.
26. Vleeming W, van de Kuil A, te Biesebeek JD, Meulenbelt J, Boink AB. Effect of nitrite on blood pressure in anaesthetized and free-moving rats. Food Chem Toxicol. 1997;35:615-619.
27. Kirima K, Tsuchiya K, Sei H, Hasegawa T, Shikishima M, Motobayashi Y, et al. Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO. Am J Physiol Heart Circ Physiol. 2003;285:H589-H596.
28. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409:622-626.
29. Jaszewski AR, Fann YC, Chen YR, Sato K, Corbett J, Mason RP. EPR spectroscopy studies on the structural transition of nitrosyl hemoglobin in the arterial-venous cycle of DEANO-treated rats as it relates to the proposed nitrosyl hemoglobin/nitrosothiol hemoglobin exchange. Free Radic Biol Med. 2003;35:444-451.
30. Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye ME, Shelhamer JH, et al. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci USA. 2000;97:9943-9948.
31. Kosaka H, Tanaka S, Yoshii T, Kumura E, Seiyama A, Shiga T. Direct proof of nitric oxide formation from a nitrovasodilator metabolised by erythrocytes. Biochem Biophys Res Commun. 1994;204:1055-1060.
32. Cantilena LR Jr, Smith RP, Frasur S, Kruszyna H, Kruszyna R, Wilcox DE. Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy. J Lab Clin Med. 1992; 120:902-907.
33. Hall DM, Buettner GR. In vivo spin trapping of nitric oxide by heme: electron paramagnetic resonance detection ex vivo. Methods Enzymol. 1996;268:188-192.
34. Bazzani C, Bini A, Cainazzo MM, Meletti E, Tomasi A, Bertolini A, et al. High blood levels of nitric oxide in rats subjected to prolonged respiratory arrest and their modulation during adrenocorticotropin-induced resuscitation. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:53-59.
35. Glover RE, Germolec DR, Patterson R, Walker NJ, Lucier GW, Mason RP. Endotoxin (lipopolysaccharide)-induced nitric oxide production in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated Fischer rats: detection of nitrosyl hemoproteins by EPR spectroscopy. Chem Res Toxicol. 2000;13:1051-1055.
36. Baker JE, Felix CC, Olinger GN, Kalyanaraman B. Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci USA. 1988;85:2786-2789.
37. Nakazawa H, Ichimori K, Shinozaki Y, Okino H, Hori S. Is superoxide demonstration by electron-spin resonance spectroscopy really superoxide? Am J Physiol. 1988;255:H213-H215.
38. Kosaka H, Sawai Y, Sakaguchi H, Kumura E, Harada N, Watanabe M, et al. ESR spectral transition by arteriovenous cycle in nitric oxide hemoglobin of cytokine-treated rats. Am J Physiol. 1994;266:C1400-C1405.
39. Suzuki H, Iijima K, Moriya A, McElroy K, Scobie G, Fyfe V, et al. Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia. Gut. 2003;52:1095-1101.
40. Walters CL. The exposure to humans to nitrite. Oncology. 1980;37:289-296.
41. Doyle MP, Pickering RA, DeWeert TM, Hoekstra JW, Pater D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem. 1981;256:12393-12398.
42. Ignarro LJ, Gruetter CA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochim Biophys Acta. 1980;631:221-231.
43. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
44. Moulds RF, Jauernig RA, Shaw J. A comparison of the effects of hydrallazine, diazoxide, sodium nitrite and sodium nitroprusside on human isolated arteries and veins. Br J Clin Pharmacol. 1981;11:57-61.
45. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther. 1981;219:181-186.
46. Matsunaga K, Furchgott RF. Interactions of light and sodium nitrite in producing relaxation of rabbit aorta. J Pharmacol Exp Ther. 1989;248:687-695.
47. Laustiola KE, Vuorinen P, Porsti I, Metsa-Ketela T, Manninen V, Vapaatalo H. Exogenous GTP enhances the effects of sodium nitrite on cyclic GMP accumulation, vascular smooth muscle relaxation and platelet aggregation. Pharmacol Toxicol. 1991; 68:60-63.
48. Demoncheaux EA, Higenbottam TW, Foster PJ, Borland CD, Smith AP, Marriott HM, et al. Circulating nitrite anions are a directly acting vasodilator and are donors for nitric oxide. Clin Sci (Lond). 2002;102:77-83.
49. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA. 2001;98:12814-12819.
50. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9:1498-1505.
51. Okamoto M, Tsuchiya K, Kanematsu Y, Izawa Y, Yoshizumi M, Kagawa S, et al. Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in kidney. Am J Physiol Renal Physiol. 2005;288:F182-F187.
52. Szabo A, Heemann U. Ischemia reperfusion injury and chronic allograft rejection. Transplant Proc. 1998;30:4281-4284.
53. Hirabayashi G. The role of NO in renal ischemia-reperfusion injury in rats. J Tokyo Med Univ. 2000;58:175-182.
54. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med. 1995;1:804-809.
55. Cadnapaphornchai MA, Ohara M, Morris KG Jr, et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol. 2001;280:F592-F598.
56. Martin PY, Ohara M, Gines P, Xu PL, St John J, Niederberger M, et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest. 1998;101:235-242.